Generalized anxiety disorder in type 2 diabetes mellitus: prevalence and clinical characteristics.
CONCLUSION: Since the prevalence of GAD was greater among T2DM patients than the general population, public health initiatives are needed to prevent and treat GAD in T2DM patients, specifically those with the above mentioned risk factors.
PMID: 32321059 [PubMed - as supplied by publisher]
Source: Revista Brasileira de Psiquiatria - Category: Psychiatry Authors: Huang CJ, Hsieh HM, Tu HP, Jiang HJ, Wang PW, Lin CH Tags: Braz J Psychiatry Source Type: research
More News: Anxiety | Cardiology | Congestive Heart Failure | Databases & Libraries | Depression | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Generalized Anxiety Disorder (GAD) | Health Insurance | Heart | Heart Failure | Insulin | Insurance | International Medicine & Public Health | Men | Metformin | Peripheral Vascular Disease (PVD) | Psychiatry | Study | Taiwan Health
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024